- Kim et al - TICO trial - Fewer adverse events with ticagrelor monotherapy after 3 months DAPT
- Dangas et al - TWILIGHT-COMPLEX substudy - Significant less bleeding with ticagrelor monotherapy after complex PCI
- Lim et al - EXPAND trial - MitraClip safe and effective in real-world setting
- Ho et al - MAVERICK-HCM trial - Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy
- Raal et al - Evinacumab significantly reduces LDL-C in homozygous FH patients
- Bhatt et al - REDUCE-IT EPA analysis - Higher serum levels of eicosapentaenoic acid correlate with reduced CV events
Posted on
Previous Article
« For refractory obstructive sleep apnea, surgery may be effective Next Article
ACC.20/WCC Highlights Podcast Part 2 of 3 »
« For refractory obstructive sleep apnea, surgery may be effective Next Article
ACC.20/WCC Highlights Podcast Part 2 of 3 »
Table of Contents: ACC/WCC 2020
Featured articles
Heart Failure and Cardiomyopathies
Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy
Vericiguat shows beneficial effects in a very high-risk HF population
No role for sodium nitrite in out-of-hospital cardiac arrest
Vascular Medicine and Thromboembolism
Rivaroxaban and aspirin effective and safe for PAD patients
TAILOR-PCI misses endpoint but still provides valuable insights
Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?
Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel
Apixaban offers new perspective for cancer patients in need of anticoagulation
Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery
Interventional Cardiology
TAVR safe and effective in low-risk bicuspid aortic stenosis patients
TAVR model reveals differences in hospital outcomes
2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis
Renal denervation better than sham for blood pressure
Infusion of ethanol in the vein of Marshall for persistent AF
Atrial Fibrillation/Acute Coronary Syndrome
Fewer adverse events with ticagrelor monotherapy after 3 months DAPT
TWILIGHT sub-study: same outcomes for diabetes patients
TWILIGHT sub-study: complex PCI patients
LAAO Watchman registry data positive
Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days
Genetics and Prevention
Homozygous FH responds to alirocumab
Evinacumab significantly reduces LDL-C in homozygous FH patients
Higher serum levels of eicosapentaenoic acid correlate with reduced CV events
Quit smoking: vaping + counselling helps
Related Articles
September 7, 2020
Vericiguat shows beneficial effects in a very high-risk HF population
September 8, 2020
TWILIGHT sub-study: complex PCI patients
September 8, 2020
Infusion of ethanol in the vein of Marshall for persistent AF
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com